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The mouse H-2K, D, and L genes of the MHC encode highly polymorphic
antigens expressed at the cell surface. While their polymorphism is reflected in
graft rejections, these class I MHC antigens mediate recognition processes
involving cells ofthe immune system (1).
A large number ofmAbs havebeen raised against these polymorphic molecules
(2-6). They have been used to analyze in details the expression ofdifferent H-2
antigens in different tissues and to approach questions dealing with the interac-
tion between the T cell receptor and foreign antigens presented in association
with MHC molecules. Better knowledge of the portion of the H-2 antigen
recognized by the different mAbs would be helpful in delineating epitope
structures.
Three external domains of MHC class I genes are encoded in separate exons
ofthe gene. Several groups have taken advantage ofthis fact to generate hybrid
antigens in which given domains have been replaced by the corresponding ones
of another antigen (7-18). These exon-shuffling experiments have also been
used to produce interspecies HLA/H-2 (11, 19) as well as class 11/class I hybrids
(20). In several instances, this has permitted the assignment ofparticular alloan-
tigenic determinants recognized by mAbs or by allospecific or virus-specific
CTLs to a given domain.
To refine such studies and more precisely map epitopes recognized by mAbs,
it is necessary to obtain recombinants within the domains. However, it is often
difficult to construct the appropriate recombinants because convenient restric-
tion endonuclease sites are generally lacking. Site-directed mutagenesis can be
used, but requires a new construction for each new mutant sequence. Weber
and Weissmann (21) have used in vivo recombination in Escherichia coli to
produce chimeric IFN sequences. We have improved this technique in such a
way as to obtain many recombinants in which the recombination point can now
be easily predicted and detected. In the previous study (22), we analyzed several
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parameters involved in the rate of recombination and the characteristics of
recombinants produced . The procedure can be applied to any pair of homologous
sequences displaying up to 10% of mismatched nucleotides and, perhaps, more.
In this way, dozens of chimeric H-2 sequences differing by as few as one amino
acid can be easily produced in one experiment.
Since previous studies (7, 10, 12, 15, 18) have assigned most alloantigenic
determinants to the two first external domains of H-2 antigens (N and C 1), we
have predominantly constructed chimeric H-2 antigens with recombination
points located within these two domains. 11 different chimeric H-2 sequences
have been obtained in which the 5' part is derived from H-2Kd and the 3' part
from H-2D". These new H-2 sequences, introduced into a eukaryotic expression
vector, were expressed in Ltk- cells after transfection. The expressed chimeric
antigens were tested with a panel of 61 mAbs specific for either H-2Kd or H-
2Dd. This has allowed us to assign small peptidic sequences (2-6 amino acids) as
part of the antigenic determinants recognized by 59 out of 61 mAbs .
Materials and Methods
DNA Sequencing.
￿
Recombinants were sequenced by the Maxam and Gilbert procedure
(23) after end labeling with T4 polynucleotide kinase or terminal deoxynucleotidyl
transferase.
Subdoning into VcDNA.
￿
For expression in transfected cells, we used a vector (VcDNA)
constructed and kindly provided by Dr. R. Breathnach and described in reference 24.
For each recombinant, the 1,169-bp Eco RI-Nru I fragment was purified by electropho-
resis in low-gelling agarose and ligated, without purifying the DNA from agarose, into
VcDNA cut by Eco RI and Hpa I restriction endonucleases.
Monoclonal Antibodies.
￿
The mAbs used in this work have been previously described
(2-6). Culture supernatants of hybridoma cells were used at a dilution of 1 :10, ascites
fluids at a dilution of 1 :100, and protein A-Sepharose-purified Ig at a dilution of 1 :200
to 1 :800 .
Transfections.
￿
10 ug of recombinant plasmid were coprecipitated by ethanol with 300
ng of pAGO containing the HSV1 thymidine kinase (tk) gene (25). The pellet was
resuspended and transfected with calcium phosphate into 106 freshly plated Ltk- cells.
After 2 d, transfected cells were selected in HAT medium. 2 wk later, the cells were
trypsinized, allowed to react with mAb 34-1-2 in ice for 30 min, washed, stained with
FITC-conjugated goat anti-mouse Ig serum under the same conditions, and washed. The
10% brightest cells were collected under sterile conditions by flow cytometry.
Immunofluorescence Analyses.
￿
Transformed cells (106) were incubated with 50 ul of
mAb in ice for 30 min and then washed with HBSS supplemented with 5% heat inactivated
FCS and 0.1 % azide. The cells were then stained with FITC-conjugated goat F(ab')2 anti-
mouse F(ab')2 and goat F(ab')2 anti-mouse Fc (Cappel Laboratories, Cochranville, PA) in
ice for 30 min and washed as mentioned above. Stained cells were fixed in HBSS containing
1 % paraformaldehyde. Typically, 2 x 10' cells were analyzed by flow cytometry.
Flow CytometryAnalyses and Sorting.
￿
FITC-labeled cell flow cytometry was performed
using a cytofluorograf 50HH (Ortho Diagnostic Systems Inc ., Westwood, MA) with the
488 nm line from an argon ion laser (lexel 95-4) at 200 mW power. The low-angle light
scattering was used for gating, thus eliminating the contribution of debris from the
fluorescence histograms. The exciting line of the laser was excluded by a dichroic filter
and a narrow pass filter (514-540 nm). Analyses and sorting were monitored by a
microprocessor system 2150 (Ortho Diagnostic Systems Inc.).
Results
Construction ofChimeric H-2 Sequences.
￿
The technique used to obtain chimeric
H-2 sequences is depicted in Fig. 1 . It has been described in detail elsewhereABASTADO ET AL.
￿
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FIGURE 1 .
￿
Production of chimeric H-
2 sequences by the snail technique. The
plasmid pKKD carries, between the H-
2Kd and the H-2D' sequences, the kana-
mycin resistance gene (Km'). Lineariza-
tion within one ofthe two H-2 sequences
yields a snail that, upon transformation
into E. coli, can recircularize by intra-
molecular recombination within the re-
gions of homology. Recombinants have
lost the Km' marker.
(22), as part of an analysis of the molecular mechanism of intramolecular
recombination. Briefly, the plasmid pKKD carried the H-2Kd sequence derived
from a cDNA isolated in our laboratory (26). Downstream and in the same
orientation it also carried the H-2Dd sequence derived from the cDNA pAG64
(27). In between, we inserted the kanamycin resistance gene (Kmr) of the Tn5
transposon. To obtain recombinants, pKKD DNA was cut in one of the two H-
2 sequences which, after transformation into E. coli, led to intramolecular
homologous recombination at high frequency. 10 ng of linearized pKKD were
usually sufficient to produce 100-200 recombinants. Recircularization by end-
to-end ligation was sometimes observed but yielded <10-20% ofthe transform-
ants. Actual recombinants lost the Kmr marker, and were easily scored as
kanamycin sensitive. Intramolecular recombination between the two H-2 se-
quences usually occurred at some distance from the site where pKKD had been
cut. We found that the frequency ofrecombination decreases gradually with the
distance from this cutand we used this property to isolate recombinants all along
the H-2 sequence. Oligonucleotide probes (14-mers) specific for H-2Kd or H-2Dd
have been used to map the recombination point by colony hybridization on the
transformants.
Due to the order of the Kd and Dd sequences on the initial plasmid pKKD, all
recombinants obtained had the 5' end of H-2K' and the 3' end of H-2Dd.
Therefore, despite the fact that pAG64 is not a complete cDNA copy of H-2Dd
and lacks its first 40 amino acids, all recombinants potentially encoded complete
H-2 heavy chains, of which, the signal sequence and the 40 first amino acid were
always derived from H-2Kd.
Because we were interested in mapping alloantigenic determinants recognized
by mAbs and since previous studies (7, 10, 12, 15, 18) have shown that these
were predominantly located in the first and second external domains (N and
CI), we chose 22 recombinants out ofwhich 18 were recombined within those
two domains. We sequenced those 22 recombinants and found 11 different
sequences. None ofthe recombinants had suffered deletions, insertions, or point
mutations. The positions ofthe 11 recombination points are indicated in Fig. 2
(R1 to R11). Four (R1 to R4) are recombined within the first domain, five (R5
to R9) within the second domain, and two (R10 and R11) within the NH2-
terminal part of the third domain.
Expression of the Chimeric H-2 Sequences.
￿
The 11 recombinant H-2 sequences
were subcloned into the VcDNA vector (24). This plasmid had been devised to330
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TABLE I
Expression of Chimeric H-2 in L Cells
express cDNA sequences under control of the SV40 early Tantigen promoter.
It has been previously used (24) to express a full-length H-2Kd cDNA sequence
to a significant level in L cells. After cotransfection with the HSV1 tk gene into
mouse Ltk- cells (H-2k), TK' transformants were selected in HAT medium. The
bulk of transformants were analyzed by flow cytometry using the mAb 34-1-2
specific for both H-2Kd and H-2Dd (2). This antibody gave no background on
Ltk- cells. The percentage ofpositive cells and the level ofexpression was found
to vary from one cell line to the other. For each recombinant, we isolated, by
flow cytometry, cells giving comparable levels of fluorescence after staining with
this mAb. This level was in the same order offluorescence as that obtained with
BALB/c 3T3 cells (H-2d). The mean fluorescein value obtained with 34-1-2 or
T0122 (another Kd-and Dd-specific mAb) was at least 10 times higher than that
observed for untransformed cells (Table I), although some transformants re-
quired numerous cycles ofcell sorting to achieve this result.
Reactivity ofH-2-specific mAbs on Cell Lines Expressing Chimeric H-2Antigens.
￿
A
total of 77 H-2-specific mAbs were tested on the 11 cell lines expressing chimeric
H-2 antigens by indirect immunofluorescence using a flow cytometer. All anti-
bodies were negative on L cells. 58 were specific for H-2Dd but negative for H-
2Kd, 3 were specific for H-2Kd but not for H-2Dd, 2 were positive with both
antigens, and 14 were negative with both antigens. An example ofthe reactivity
of a Dd-specific mAb (H147) on the different cell lines is shown in Fig. 3 and a
summary of the results obtained with Kd- and/or Dd-specific mAbs is presented
in Fig. 4.
15 mAbs (Fig. 4, group A) were found to recognize Dd but none of the
recombinants . 11 mAbs (group B) were found to recognize Dd and R1 but none
of the other recombinants. By comparing the sequences of R1 and R2 (Fig. 2),
three amino acid residues ofDd are identified that differ from Kd residues; they
are R62, E63, and R65 and are thus likely to be critical for the recognition by
these 11 mAbs. This indicates that at least one of these residues belong to the
Cells
Mean
34-1-2
of fluorescence
T0122
L-Kd 81 185
L-Dd 519 541
L 5 13
R1 63 166
R2 289 251
R3 272 507
R4 329 534
R5 232 391
R6 54 128
R7 232 252
R8 151 188
R9 145 173
R10 369 505
R11 118 268332
￿
FINE MAPPING OF EPITOPES
FIGURE 3 .
￿
Flow cytometry analysis ofcells ex-
pressing the different chimeric H-2 antigens
after staining with mAb H-147 (3) . Cells were
stained as described in Material and Methods
section . 2 X 10 4 cells were analyzed. Abscissa,
relative fluorescence intensity with linear am-
plification in arbitrary units ; ordinate, number
of cells . L, untransfected cells ; L-Dd, L cells
transfected with H-2D d ; L-Kd , L cells trans-
fected with H-2K d;R1-R11, L cells transfected
with the correspondingKd/Dd recombinant .
FIGURE 4 .
￿
Reactivity of mAbs on L cells expressing chimeric H-2 antigens . (Left) Schematic
drawing of the parental and chimeric H-2 antigens . The hatched region corresponds to the
K'-derived portion of the antigens. (Right) Summary of the flow cytometry analysis of the
different cell lines expressing these antigens after staining with Kd- and/or D'-specific mAbs .
mAbs yielding the same pattern have been grouped . A black square indicates that the
recombinant is recognized while a white square indicates that it is not . Hatched squares
correspond to dull staining. List of the mAbs grouped according to the pattern of reactivity
on the chimeric H-2 antigens: (A) TO 107, TO 111, TO116, TO119, TO120, TO 128, TO129,
TO131, TO133, TO137, TO138, TO139, TO142, TO143, 66-2-4 ; (B) TO124, TO127, TO132,
TO134, TO136, TO141, TO144, 34-421, 27-11-13, 28-8-6, T14c ; (C)T0112, TOI 13, T0114,
T0115, T0117, TO121, TO123, TO126, TO130, 28-11-5, 34-420, 34-5-8, 66-13-6, H81-199-
1, T148 ; (D) TO102, TO103, TO104, TO108, TO109, TO110, T0118, T0125,66-4-8,66-13-
5, 66-13-19, H147 ; (E) TO105, TO106; (F) 34-2-12 ; (G) 20-8-4, F35-119-18 ; (H) 31-3-4 ; (I)
34-1-2, TO122 ; (J) TO 145 ; (K) 23A-5-21 .
epitope(s) recognized by group B mAbs . Residues are given in the one-letter
code and their positions are numbered as in Fig . 2.
As shown in Fig . 4, group C, 15 mAbs recognized Dd , Rl, R2, R3, R4, and
R5 at comparable levels, but not R6, R7, R8, R9, R10, R11, norKd . Comparing
the sequences of R5 and R6 (Fig . 2) allows us to assign at least part of the
epitope(s) recognized by groupC mAbs to residues L95, W97, A99, E104, and
G107 . 12 mAbs (group D) recognizedDd , and RI to R8 at comparable levels but
not R9, R10, R11, nor Kd (see Fig . 3 as an example) . By comparing R8 and R9,
we deduced that residues M138, and Q141 belong to the epitope(s) recognizedABASTADO ET AL.
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by these mAbs. 2 mAbs (group E) recognized Dd and R1 to R9, but not R10,
R11, nor Kd. Consequently, the recognized epitope(s) contains residues A152,
R155, D156, K173, N174, A177, and/or P184.
As shown in Fig. 4, group F, 1 mAb (34-2-12) was positive on Dd and all
recombinants but negative on Kd. Its epitope was thus mapped in the third
domain, downstream from position R193.
Out of the Kd-specific mAbs, 2 were found negative on Dd, R1, R2, R3, and
R4, but positive on R5 to RI I as well as Kd (group G). Therefore, residues Q82,
and K89 are part of the epitope(s) recognized by these mAbs.
1 Kd-specific mAb (31-3-4) was found to react with R10, R11, and Kd, but not
with R1 to R9 nor Dd (group H) . Thus its epitope contains residues D152, Y155,
Y156, E173, L174, E177, and/or S184.
2 Dd-specific mAbs (T0145 and 23-5-2D) gave a more complex pattern
(groupsf and K). For example, TO 145 was positive on Dd, R4, and R5, dull on
R1 and R2, but negative on R3, R6 to R11, and Kd.
The 14 mAbs negative with both Kd and Dd, but positive with other mouse
MHC class I antigens (23-10-1, 28-14-8, 30-5-7, 28-13-3, 66-3-5, 64-3-7, H-154,
H-118, H-117, H-149, H-122, H-148, H-121, and H-108) were negative on all
recombinants (data not shown), while the 2 mAbs positive with Kd and Dd were
positive on all recombinants (group I).
Discussion
We have used in vivo recombination in E. coli to produce chimeric H-2
antigens. This method, depicted in Fig. 1 and described in detail elsewhere (22),
is derived from the original method of Weber and Weissmann (21) with major
improvements. It is based on the recircularization of a linear DNA molecule
carrying homologous sequences. By cutting the parental plasmid in one of the
two H-2 sequences at different sites, any type of recombinant can be obtained
(22). Oligonucleotide probes specific for one or the other parental sequence
allow rapid mapping of the recombination point.
Of 22 sequenced recombinants, 11 had different sequences. None of them
had suffered rearrangement, nor point mutation . These 11 chimeric sequences
were subcloned in an expression vector and transfected in Ltk- cells. Transfected
cells were screened by indirect immunofluorescence, using the mAb 34-1-2
recognizing both parental sequences H-2K' and H-2D'. For all recombinants,
positive cells were detected. This result implies that all recombinants are ex-
pressed on the cell surface. Thus, all signals necessary for the translation, the
posttranslational modification, the transport to the cell surface, and the insertion
into the membrane, as well as the correct foldingand proper recognition by the
antibody, are functional in the hybrid molecules. Indeed, sequence elements
involved in these processes probably exist in homologous positions in the two
parental sequences and may be conserved upon recombination. For example,
both H-2Kd and H-2Dd antigens have cystein residues at positions 100 and 163
involved in a disulphide bridge known to be important for the folding of the
second external domain (28). As such, all recombinants would be expected to
and do have cystein residues at these positions. Similarly, it is possible that many
characteristics of the tertiary structure, as well as characteristics of the primary334
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structure, areconserved within theparental molecules and recombinants derived
from them. Superposition ofthe crystallographic structure of three different IgS
has revealed a high degree of coincidences in atomic positions (29). Ifthe same
holds true for H-2 class I molecules, recombinant molecules may thus all share
the same basic regular structure as the parental ones. Several lines of evidences
indicate that the H-2 multigene family has evolved by different kinds of homol-
ogous recombination (unequal crossing-over, intra-, and interallelic conversion).
The latter may create a very large diversity (30), and our results suggest that
many of the different H-2 sequences thus generated may be functional. This
argument, however, must be taken with caution, since it was found that Q7/Kd
and Q7/Ld (14), as well as some combinations ofclass I/class II (20) exon-shuffled
recombinants, are not expressed on the cell surface.
We have tested 77 mAbs on these chimeric H-2 antigens. Most of them (75)
gave a simple pattern of reactivity: mAbs recognizing both parental sequences
recognized all recombinants; mAbs recognizing neither Kd nor Dd recognized
none of the recombinants. Dd-specific mAbs recognized the most 5' recombi-
nants, whereas Kd-specific mAbs recognized the most 3' recombinants. Only two
mAbs presented a more complex pattern. This pattern, observed reproducibly
with different batches of mAbs, is difficult to explain. It likely indicates that the
structure recognized by these mAbs was perturbed in some recombinants. The
fact that this situation was infrequent a posteriori shows the method can be
utilized to define the epitopes recognized.
The fact that a given mAb recognizes all recombinants harboring a certain
residue but none of those lacking this residue indicates that this residue is
necessary for the recognition, although this alone may not be sufficient. There-
fore, residues thus identified are likely to be only part of the epitope recognized
by the mAb.
When two recombinants differing at multiple amino acid positions present a
distinct pattern ofreactivity with the same mAb, it would mean that at least one
of these residues belongs to (or influences) the epitope recognized by the mAb.
When those multiple changes are in neighboring positions and particularly if
they involve charged amino acids, several of these residues may influence the
epitope.
Some of the mAbs analyzed in the present study have been previously char-
acterized by exon shuffling and/or site-directed mutagenesis. TO107, TO119,
T0120, T0129, T0131, T0133, and T0137 (Fig. 4, group A) were previously
mapped to the N domain by Ld/Dd (15) and D'/Dd (18) recombinants by exon
shuffling. Our data (Fig. 4) confirm these previous assignments and refine the
recognized portion of the molecule to residues 1-52. In addition, we deduce
that these mAbs recognize positions where the Dd sequence differs from that of
Ld, D', and Kd. As shown in Fig. 5, the only residues between 1 and 52 that
satisfy this criterion are residues S2, F17, and 152.
TO124, TO136 (Fig. 4, group B) were previously mapped to the N domain by
Ld/Dd and D'/Dd exon-shuffled recombinants, whereas 34-421 and 28-8-6 (group
B) were mapped to the N domain by an Ld/Dd exon-shuffled recombinant (15,
18). Moreover, the former three mAbs were shown to recognize a mutated Ld
in which residues 163, Q65, and 166 were replaced with the corresponding DdABASTADO ET AL.
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amino acids (31). As shown by our data (Fig. 4), these mAbs recognize residues
R62, E63, and/or R65. Since residue 62 is identical between Ld and Dd (R) and
residue 66 is identical between Kd and Dd (R), results obtained by different
approaches are in full agreement.
We extended such refinements to eight other mAbs, five of which had been
mapped to the N domain by Ld/Dd exon-shuffled recombinants (TO 127, TO 132,
TO134, TO141, and TO144) (15) . Nevertheless, a possible contribution of C1
had been suggested by a D'/Dd exon-shuffled recombinant (18). In addition,
T0127 and T0144 were shown to recognize the mutated Ld with residues 63,
65, and 66 from Dd while TO 132, TO 134 recognized another mutated Ld with
residues 63, 65, 66, and 70 of Dd type (31). Consistent with this observation, our
results (Fig. 4) map these mAbs to residues R62, E63, and R65. The possible
contribution of the C1 domain to the epitope cannot be further assessed since
R1 and R2 have a C1 domain derived from Dd.
mAbs 34-420 and 34-5-8 were previously mapped to C1 by Ld/Dd exon-
shuffled recombinants (8) and Ld/Dd and Dp/Dd recombinants (8, 18). We refine
this mapping to residues L95, W97, A99, E104, and/or G107 (Fig. 4). Moreover,
residues L95, W97, and G107 are excluded since they are identical between Ld
and Dd (Fig. 5). Thus, these mAbs are more likely to recognize positions A99
and/or E104. Similarly, the mAb 28-11-5 was previously mapped in C1 by Kb/Db
exon-shuffled recombinants (9). Since Kb and Db have identical residues at
positions 99, 104, and 107, it is likely to recognize the L95 and/or the W97.
From the remaining group C mAbs, six (TO112, TO 113, TO 114, TO 117, TO 121,
TO 123) had previously been mapped by DP/Dd exon-shuffled recombinants to
the C1 domain (18), in agreement with the present data (Fig. 4).
mAb 20-8-4 was previously mapped to N by Kd/Kk (13) and by Kb/Db (10)
exon-shuffled recombinants. In agreement with this mapping, we assigned resi-
dues Q82 and K99 to its epitope (Fig. 4).
mAb 34-2-12 (group F) was mapped in C1 downstream from the R193 (Fig.
4) in agreement with previous analyses suing Ld/Dd (7, 8), Q7/Dd (14), or
HLA/H-2 (11) exon-shuffled recombinants as well as truncated H-2 (20).
12 mAbs (group D) were mapped between R8 and R9 that differ only at
positions 138 and 141 (Fig. 4). Five of them (TO103, TO104, TO108, TO109,
and TO I 10) were previously mapped to the N domain by Ld/Dd exon-shuffled
recombinants, while three (TO104, TO108, and TO 109) were assigned to the N
and/or C1 domain(s) by D'/Dd recombinants (18). This apparent discrepancy is
readily explained if one notes (Fig. 5) that Ld, DP, and Dd have identical residues
at positions 138 and 141 (M and Q). It is thus sufficient to assume that part of
the epitope is contributed by amino acid 138, 141 and part by residues in the N
domain (Fig. 5). At these positions, the sequence of Dd and that of Kd should
both differ from those of Ld and DP. Four positions satisfy this criterion in the
N domain (66, 70, 81, 83). In agreement with this interpretation, four mAbs
belonging to group D (TO108, TO109, TO110, and TO118) recognize the
mutated Ld in which positions 63, 65, 66, and 70 are Dd type (31). Taken
together, these data suggest a physical interaction or proximity of residues 66-
70 to residues 138-141, inasmuch as they belong to the same epitopes.
Two Dd-specific (group E, T0105 and TO106) and one Kd-specific (group H,TABLE 11
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TO 102, TO 103, TO 110, TO 118, TO 125, 66-4-8, 66-
13-5, 66-13-19, H147
TO105, T0106
34-2-12
K'-specific
20-8-4, F35-119-18
31-3-4
M138, Q141
337
A152, R155, D156, K173, N174, A177
193-276
Q82, K89
D152, Y155, Y156, E173, L174, E177
31-3-4) mAbs were mapped between R9 and R10 (Fig. 4) between residues 152
and 184 (Fig. 2), in accordance with the previous mapping of these mAbs to the
C1 domain using DP/Dd (18) or Kd/Kk (13) exon-shuffled recombinants.
Our assignments for alloantigenic epitopes recognized by mAbs are summa-
rized in Table 11 . For 61 mAbs specific for the Kd or Dd molecules, we have
been able to assign a small number of residues to the recognized epitope. By
comparison with previous exon-shuffling studies, we have, in many cases, iden-
tified two or three critical residues.
As previously published by Darsley et al . (18), the matching of chimeric
antigens with a panel of mAbs occasionally reveals interdomain interactions.
Because a pair of class I antigens may share the same residues at a number of
polymorphic positions noncontinuous epitopes may appear continuous in exper-
iments using recombinants made from a single pair of class I antigens. The use
of the intradomain recombinants allowed us to identify additional noncontinuous
epitopes which are possibly involved in interdomain interactions.
Amino acids residues assigned here for alloantigenic determinants may, in
combination with neighboring residues, produce characteristic second-
ary/tertiary structures for which we have no information at the moment. The
three-dimensional structure of class I molecules should help in interpreting these
observations. Crystallography data analysis is near completion and reveals close
interactions between N and C 1 giving rise to a platform ß strand on top of which
are two a helices connected by a loop (32; Wiley, D., unpublished observations).
The region 152-182 would be one of these alpha helices. Interestingly, this
region also contains the epitopes recognized by allogeneic CTLs specific for the
Monoclonal antibodies Residues
D'-specific
TO107, TO119, TO120, TO129, TO131, TO133, S2, F17, 152
T0137
TO111, TO116, TO128, TO138, TO139, TO142, 2-52
TO 143, 66-2-4
TO124, TO127, TO136, TO141, TO144, 34-421, 27- R62, E63, R65
11-13, 28-8-6, T14C
TO132, T0134 R62, E63, R65, R66, N70
34-420, 34-5-8 A99, E104
28-11-5 L95, W99
T0112, TO113, TO114, TO115, T0117, TO121, L95, W97, A99, E104, G107
T0123, TO126, T0130, 66-13-6, H81-199-1, T148
TO 104, TO 108, TO 109 R66, N70, M138, Q141338
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mutant H-2Kb,1 (33) or for H-2K' (16) and the homologous region of HLA-A3
contains the determinant of influenza specific HLA-A3 restricted and allogeneic
CTLs specific for HLA-A3 (34).
The available techniques, including those described here, now permit to readily
generate a large number of chimeric H-2 molecules. It appears likely that the
use of several pairs of H-2 antigens would produce a large set of detailed
serological data, possibly pinpointing single amino acid residues participating in
various epitopes.
Summary
11 intradomain recombinants between H-2Kd and H-2Dd were produced using
an original technique based on in vivo recombination in Escherichia coli. After
transfection into mouse L cells, all these recombinants were expressed at high
levels on the cell surface. The specificities of 77 mAbs were examined on these
cell lines. mAbs could be organized in 12 groups. In each group, a small number
of amino acids participating in the recognized epitope(s) were identified. In a
few instances, noncontinuous epitopes comprising amino acids belonging to
different domains of the antigen were found. The data thus obtained are
compatible with those produced in previous exon-shuffling experiments, but
permit a much more precise definition of recognized epitope(s).
The authors wish to thank D. H. Sachs, F. Figeroa, and M. Pierres for kindly providing
mAbs; H . Gachelin, Ph. Metezeau (S .C.9 Inserm, Pasteur), and M. Walker for help in
flow cytometry analyses; and V. Caput for typing the manuscript.
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